Tianjin TEDA Biomedical Engineering Company Limited reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was CNY 116.01 million compared to CNY 117.38 million a year ago. Net loss was CNY 7.2 million compared to net income of CNY 0.975176 million a year ago. Basic loss per share from continuing operations was CNY 0.0038 compared to basic earnings per share from continuing operations of CNY 0.00052 a year ago.
For the six months, sales was CNY 205.21 million compared to CNY 241.79 million a year ago. Net loss was CNY 13.25 million compared to net income of CNY 0.809551 million a year ago. Basic loss per share from continuing operations was CNY 0.00699 compared to basic earnings per share from continuing operations of CNY 0.00043 a year ago.